Nearly 40% of Type 2 diabetes patients stop taking their second-line medication

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin -- the go-to primary drug for glucose management -- to control their blood sugar levels. But adherence to these second-line drugs can be hit or miss, reports a new study.  Among patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), half (50%) discontinued treatment. 

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin -- the go-to primary drug for glucose management -- to control their blood sugar levels. But adherence to these second-line drugs can be hit or miss, reports a new study.  Among patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), half (50%) discontinued treatment. 

Read more https://www.sciencedaily.com/releases/2023/12/231212112312.htm